Year: 2026
Type: article
Abstract: Achieving a clinical cure can prevent the subsequent development of liver cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. Therefore, clinical cure is a key indicator for evaluating antiviral therapy discontinuation and commercialization of new drugs. However, the benefits vary among patients with different disease states and levels of disease severity following clinical cure. Therefore, in clinical practice, in addition to focusing on the advantageous population cure, it is also important to emphasize priority and special populations.This review focuses on the selection of priority and special populations, the stratification and organization of cure strategies, clinical benefits, risk management measures, and the assistance provided to clinicians in implementing precise, cure-oriented treatment approaches for the clinical cure of chronic hepatitis B.
Source: PubMed Central
Authors: Ding Yang, Dou Xiaoguang
Institution: Sheng Jing Hospital
Language: Chinese
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225307477